<SEC-DOCUMENT>0000950170-24-055612.txt : 20240508
<SEC-HEADER>0000950170-24-055612.hdr.sgml : 20240508
<ACCEPTANCE-DATETIME>20240508160525
ACCESSION NUMBER:		0000950170-24-055612
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20240508
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240508
DATE AS OF CHANGE:		20240508

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DYNAVAX TECHNOLOGIES CORP
		CENTRAL INDEX KEY:			0001029142
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				330728374
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34207
		FILM NUMBER:		24925822

	BUSINESS ADDRESS:	
		STREET 1:		2100 POWELL STREET
		STREET 2:		SUITE 720
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
		BUSINESS PHONE:		5108485100

	MAIL ADDRESS:	
		STREET 1:		2100 POWELL STREET
		STREET 2:		SUITE 720
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>dvax-20240508.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2024-05-08T13:42:52.1659+00:00 -->
<!-- Copyright (c) 2024 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:dvax="http://www.dynavax.com/20240508">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_75becf8f-f109-4bae-842c-7e6b3c939eca" name="dei:AmendmentFlag" contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d">false</ix:nonNumeric><ix:nonNumeric id="F_4e225ced-fb02-4b4f-9e9a-b32a00633a57" name="dei:EntityCentralIndexKey" contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d">0001029142</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="dvax-20240508.xsd"/></ix:references><ix:resources><xbrli:context id="C_2db3973c-8965-47ee-910d-aaea40667e8d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001029142</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-08</xbrli:startDate><xbrli:endDate>2024-05-08</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
  <p style="border-top:2.25pt double #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:5.75pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">UNITED STATES<br/>SECURITIES AND EXCHANGE COMMISSION<br/></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">WASHINGTON, D.C. 20549</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">FORM </span><span style="font-size:18pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ad6185ca-5257-49be-a98e-a95167b9594b" contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">8-K</span></ix:nonNumeric></span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">CURRENT REPORT</span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.02986111111111111in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Date of Report (Date of earliest event reported): </span><span><ix:nonNumeric id="F_6b55f726-1acb-40e9-9b2c-7ec5742e7863" contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">May 08, 2024</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="margin-left:40%;font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:24pt;font-family:Times New Roman;"><ix:nonNumeric id="F_70eb8451-bd9d-4903-9893-5e89ee02ba6a" contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:24pt;font-family:Times New Roman;min-width:fit-content;">Dynavax Technologies Corporation</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">(Exact name of Registrant as Specified in Its Charter)</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:20%;"/>
    <td style="width:1%;"/>
    <td style="width:20%;"/>
    <td style="width:18%;"/>
    <td style="width:41%;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_c2c1c5ee-ca76-4bb8-8725-d1e07103cd80" contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_d830263e-189a-4788-a098-058756b10993" contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">001-34207</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_3219ff50-3915-43e5-a6b6-0f4755a121fe" contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">33-0728374</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(State or Other Jurisdiction<br/>of Incorporation)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Commission File Number)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(IRS Employer<br/>Identification No.)</span></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_94b7fb45-27a9-4741-be24-1619db7ec962" contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2100 Powell Street, Suite 720</span></ix:nonNumeric></span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_69a38850-caeb-433f-8098-a35460ea1010" contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Emeryville</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">, </span><span><ix:nonNumeric id="F_66f5dee4-4cb8-4d5f-8e78-59c20ec660e9" contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">California</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_9c7afb6d-53b3-4d2e-b89e-ab8535e9b9e8" contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">94608</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Address of Principal Executive Offices)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.125in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.02986111111111111in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Registrant&#8217;s Telephone Number, Including Area Code:</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_356321f3-54ef-41b3-ab22-993d50760ae4" contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">510</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_b2c7cda4-0c75-4250-9046-58ad8b7696ea" contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">848-5100</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;"/>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.125in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">(Former Name or Former Address, if Changed Since Last Report)</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:9pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c0e8c46e-b78c-4493-b2d1-8dc6f0f5a35b" contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7148ba86-7055-4882-8614-d125d96b4ff3" contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f70fc3d6-3ec2-4608-8dcb-9f73ce6c3596" contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0ba37612-ae59-435a-9d36-37e8919874c6" contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:9pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:38%;"/>
    <td style="width:1%;"/>
    <td style="width:15%;"/>
    <td style="width:1%;"/>
    <td style="width:45%;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:1px solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"><br/>Title of each class</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.011pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:1px solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Trading<br/>Symbol(s)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.011pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:1px solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"><br/>Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_f66454e4-3551-4ff2-866d-5f840b1ff944" contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Common Stock, $0.001 par value</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_757c5e5c-14b4-49ea-b5e2-24aff97a6351" contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">DVAX</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_1a2dd896-4895-4e85-a860-e4238f16b684" contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Nasdaq Global Select Market</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8239;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8239;240.12b-2 of this chapter).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Emerging growth company </span><span style="font-size:10pt;"><ix:nonNumeric id="F_9e883700-6d4a-4dd9-b514-74deb4b4b8b3" contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:2.25pt double #000000;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
  <hr style="page-break-after:always;"/>
  <div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 2.02 Results of Operations and Financial Condition.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On May 8, 2024, Dynavax Technologies Corporation ("Dynavax") issued a press release announcing its financial results for the first quarter ended March 31, 2024. A copy of the press release is attached as Exhibit 99.1 to this current report and is incorporated herein by reference.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The information with respect to item 2.02 in this current report and its accompanying exhibit shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this current report and in the accompanying exhibit shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission made by Dynavax, whether made before or after the date hereof, regardless of any general incorporation language in such filing.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 9.01 Financial Statements and Exhibits.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(d) Exhibits. The following exhibit is furnished herewith:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:4.44%;"/>
    <td style="width:95.56%;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">99.1</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="dvax-ex99_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Press release dated May 8, 2024 titled "Dynavax&#8239;Reports First Quarter 2024 Financial Results and Provides Business Updates".</span></a></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">104</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
  <hr style="page-break-after:always;"/>
  <div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SIGNATURES</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:6%;"/>
    <td style="width:44%;"/>
    <td style="width:4%;"/>
    <td style="width:46%;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Dynavax Technologies Corporation</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Date:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">May 8, 2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:1px solid;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">/s/  Ryan Spencer</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Ryan Spencer<br/>Chief Executive Officer and Interim Chief Financial Officer</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
  <hr style="page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>dvax-ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html>
 <head>
  <title>EX-99.1</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img191369596_0.jpg" alt="img191369596_0.jpg" style="width:134px;height:19px;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Exhibit 99.1</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Dynavax Reports First Quarter 2024 Financial Results</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;min-width:fit-content;">and Provides Business Updates</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:1.731%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.3917105089092185%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;">HEPLISAV-B&#174; vaccine net product revenue grew 10% year-over-year to approximately $48 million in the first quarter of 2024</font></div></div>
  <div style="margin-left:1.731%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.3917105089092185%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;">Reaffirming full year 2024 HEPLISAV-B net product revenue guidance of $265 - $280 million</font></div></div>
  <div style="margin-left:1.731%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.3917105089092185%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;">Announces U.S. FDA clearance of IND application to initiate Phase 1/2 trial of Z-1018 shingles program</font></div></div>
  <div style="margin-left:1.731%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.3917105089092185%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;">Conference call today at 4:30 p.m. ET/1:30 p.m. PT</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">EMERYVILLE, CA &#x2013; May 8, 2024 &#x2013; </font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Dynavax Technologies Corporation</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today reported financial results and provided a business update for the quarter ended March 31, 2024.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#x201c;The first quarter of 2024 saw continued year-over-year growth in quarterly HEPLISAV-B net product revenue. As we expected, growth in the U.S. hepatitis B vaccine market was slightly down during the first quarter compared to the fourth quarter due to an extended cough, cold and flu season which reduced the number of vaccination opportunities &#x2013; a dynamic observed across other non-respiratory vaccine markets beyond hepatitis B. Despite this start to the year, we remain very encouraged about the hepatitis B market opportunity, both in 2024 and longer term. We are now seeing a pickup in the market as providers have begun to shift to non-respiratory vaccine campaigns in recent weeks, our retail pharmacy partners are expected to meet their demand expectations for this year, and several top IDN systems are planning to launch new hepatitis B focused initiatives. The U.S. adult hepatitis B vaccine opportunity remains significant with over 130 million patients eligible, one of the largest addressable patient populations in the U.S., and the vast majority remaining unvaccinated,&#x201d; said Ryan Spencer, Chief Executive Officer of Dynavax.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#x201c;We&#x2019;re also excited for several upcoming milestones from our novel vaccine pipeline, including the planned initiation of a mid-stage clinical trial in shingles this year, and data readouts from our plague and shingles vaccine programs expected across 2024 and 2025. In addition to this continued execution, and bolstered by our strong financial position, we continue to evaluate strategic opportunities to accelerate growth and further diversify our portfolio.&#34;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">BUSINESS UPDATES</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;">HEPLISAV-B&#174; [Hepatitis B Vaccine (Recombinant), Adjuvanted]</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;">HEPLISAV-B vaccine is the first and only adult hepatitis B vaccine approved in the U.S., the European Union and Great Britain that enables series completion with only two doses in one month. Hepatitis B vaccination is universally recommended for adults aged 19-59 in the U.S.</font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">HEPLISAV-B vaccine achieved net product revenue of $47.8 million for the first quarter of 2024, an increase of 10% compared to $43.5 million for the first quarter of 2023. </font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">HEPLISAV-B total estimated market share in the U.S. increased to approximately 41%, compared to approximately 37% at the end of the first quarter 2023.</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">HEPLISAV-B estimated market share in the retail pharmacy segment increased to approximately 55%, compared to approximately 49% at the end of the first quarter of 2023. </font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">HEPLISAV-B estimated market share in the Integrated Delivery Networks (IDNs) and Large Clinics segment increased to approximately 55%, compared to approximately 49% at the end of the first quarter 2023. </font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">A supplemental Biologic License Application (sBLA) for HEPLISAV-B vaccination of adults on hemodialysis is currently under review by the U.S. Food and Drug Administration (FDA) with a Prescription Drug User Fee Act (PDUFA) action date planned for May 13, 2024.</font></div></div>
  <div style="flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;"></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img191369596_0.jpg" alt="img191369596_0.jpg" style="width:134px;height:19px;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Driven by the Centers for Disease Control and Prevention's Advisory Committee of Immunization Practices (ACIP) universal recommendation for adult hepatitis B vaccination, the hepatitis B vaccine market continues to expand in the U.S. and Dynavax believes the U.S. market has the potential to grow to over $800 million by 2027, with HEPLISAV-B well-positioned to achieve a majority market share.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Clinical Pipeline</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;">Dynavax is advancing a pipeline of differentiated product candidates that leverage its CpG 1018</font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;">&#174;</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;"> adjuvant, which has demonstrated its ability to enhance the immune response with a favorable tolerability profile in a wide range of clinical trials and real-world commercial use.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Shingles vaccine program:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;">Z-1018</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;">is an investigational vaccine</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;">candidate</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;">being developed for the prevention of shingles in adults aged 50 years and older.</font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">In March 2024, Dynavax received clearance of its Investigational New Drug Application (IND) by the U.S. FDA for its novel shingles vaccine program, Z-1018.</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Dynavax plans to initiate a randomized, active-controlled, dose escalation, multicenter Phase 1/2 trial to evaluate the safety, tolerability, and immunogenicity of Z-1018 compared to Shingrix&#174; in approximately 440 healthy adults aged 50 to 69. </font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Dynavax plans to initiate the Phase 1/2 trial in the second quarter of 2024 and expects to report top line immunogenicity and safety data in the second half of 2025.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Tdap vaccine program:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;">Tdap-1018 is an investigational vaccine candidate intended for active booster immunization against tetanus, diphtheria, and pertussis (Tdap).</font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Prior to advancing Tdap-1018 into a previously announced Phase 2 human challenge trial, Dynavax plans to evaluate the persistence of pertussis immunogenicity of Tdap-1018 through a long-term follow-up study of participants that completed a Phase 1 trial</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">of a booster dose of Tdap-1018 compared to an active control. </font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">The extension study is expected to follow participants for up to approximately three years following initial vaccination. Top line results from the Phase 1 extension study are expected in the fourth quarter of 2024. </font></div></div>
  <p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Plague vaccine program:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;">Dynavax is developing a plague (rF1V) vaccine candidate adjuvanted with CpG 1018&#174; currently in a Phase 2 clinical trial in collaboration with, and fully funded by, the U.S. Department of Defense.</font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">In March 2024, Dynavax and the U.S. Department of Defense executed a contract modification to add approximately $4 million to support CMC work for the plague vaccine candidate, with the agreement now totaling $38 million through 2025.</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Dynavax anticipates top line data from both the randomized, active-controlled Phase 2 clinical trial evaluating immunogenicity, safety, and tolerability, as well as the nonhuman primate challenge study of the plague vaccine candidate, in the fourth quarter of 2024.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">FIRST QUARTER 2024 FINANCIAL HIGHLIGHTS</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Total Revenues and Net Product Revenue.</font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Total revenues for the first quarter of 2024 were $50.8 million, compared to $46.9 million for the first quarter of 2023.</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">HEPLISAV-B vaccine net product revenue was $47.8 million for the first quarter of 2024, compared to $43.5 million for the first quarter of 2023. </font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Other revenue was $2.9 million for the first quarter of 2024, compared to $3.5 million for the first quarter of 2023. Other revenue primarily includes revenue from the plague vaccine agreement with the U.S. Department of Defense. </font></div></div>
  <div style="flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;"></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img191369596_0.jpg" alt="img191369596_0.jpg" style="width:134px;height:19px;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Cost of Sales - Product. </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Cost of sales - product for HEPLISAV-B the first quarter of 2024 decreased to $11.0 million, compared to $14.7 million for the first quarter of 2023. The decrease was primarily due to lower per-unit manufacturing costs as the result of previous process improvements, partially offset by a $1.3 million inventory write-off charge recorded during the first quarter of 2024.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Research and Development Expenses (R&amp;D). </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">R&amp;D expenses for the first quarter of 2024 decreased to $13.5 million, compared to $13.6 million for the first quarter of 2023. The decrease was primarily driven by the timing of clinical development costs due to the completion of clinical trials in early 2023 and activities for planned clinical trials in 2024, partially offset by increases related to investments in our CpG 1018 preclinical and clinical collaborations.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Selling, General, and Administrative Expenses (SG&amp;A). </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">SG&amp;A expenses for the first quarter of 2024 increased to $44.1 million, compared to $36.5 million for the first quarter of 2023. The increase was primarily driven by increased headcount and other investments supporting our strategic growth, including an overall increase in targeted commercial and marketing efforts designed to increase HEPLISAV-B market share and maximize the opportunities presented by the ACIP's universal recommendation.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Net Loss. </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">GAAP net loss was $8.7 million, or $0.07 per share (basic and diluted) in the first quarter of 2024, compared to GAAP net loss of $24.3 million, or $0.19 per share (basic and diluted) in the first quarter of 2023.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Cash and Marketable Securities.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> Cash, cash equivalents and marketable securities were $723.5 million as of March 31, 2024.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">2024 FINANCIAL GUIDANCE</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Dynavax is reaffirming the following full year 2024 financial guidance, based on the Company&#x2019;s current operating plan:</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">HEPLISAV-B net product revenue between approximately $265 - $280 million, including approximately $3 million in ex-U.S. sales through commercialization partnership in Germany </font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">HEPLISAV-B gross margin of approximately 80% </font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Research and development expenses between approximately $60 - $75 million</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Selling, general and administrative expenses between approximately $160 - $180 million</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Expect cash, cash equivalents and marketable securities to be higher as of December 31, 2024, compared to December 31, 2023</font></div></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Conference Call and Webcast Information</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Dynavax will host a conference call and live audio webcast on Wednesday, May 8, 2024, at 4:30 p.m. ET/1:30 p.m. PT. The live audio webcast may be accessed through the &#34;Events &amp; Presentations&#34; page on the &#34;Investors&#34; section of the Company's website at </font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">https://investors.dynavax.com/events-presentations</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. A replay of the webcast will be available for 30 days following the live event.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">To dial into the call, participants will need to register for the call using the </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">caller registration link</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> at https://investors.dynavax.com/events-presentations and under the &#x201c;Upcoming Events&#x201d; section, click on &#34;Listen to webcast.&#34;</font><font style="color:#000000;white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">It is recommended that participants dial into the conference call or log into the webcast approximately 10 minutes prior to the call.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Important U.S. Product Information</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">HEPLISAV-B is indicated for the prevention of infection caused by all known subtypes of hepatitis B virus in adults aged 18 years and older.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#xfeff;<br></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;"></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img191369596_0.jpg" alt="img191369596_0.jpg" style="width:134px;height:19px;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">For full U.S. Prescribing Information for HEPLISAV-B, please visit the following website at https://www.heplisavbhcp.com, and click the &#x201c;Prescribing Information&#x201d; link in the &#x201c;Important Safety Information&#x201d; section.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Important U.S. Safety Information (ISI)</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Do not administer HEPLISAV-B to individuals with a history of a severe allergic reaction (e.g., anaphylaxis) after a previous dose of any hepatitis B vaccine or to any component of HEPLISAV-B, including yeast.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Appropriate medical treatment and supervision must be available to manage possible anaphylactic reactions following administration of HEPLISAV-B.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Immunocompromised persons, including individuals receiving immunosuppressant therapy, may have a diminished immune response to HEPLISAV-B.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Hepatitis B has a long incubation period. HEPLISAV-B may not prevent hepatitis B infection in individuals who have an unrecognized hepatitis B infection at the time of vaccine administration.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">The most common patient-reported adverse reactions reported within 7 days of vaccination were injection site pain (23% to 39%), fatigue (11% to 17%), and headache (8% to 17%).</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">About Dynavax</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Dynavax is a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines to help protect the world against infectious diseases. The Company has two commercial products, HEPLISAV-B&#174; vaccine [Hepatitis B Vaccine (Recombinant), Adjuvanted], which is approved in the U.S., the European Union and Great Britain for the prevention of infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older, and CpG 1018&#174; adjuvant, currently used in HEPLISAV-B and multiple adjuvanted COVID-19 vaccines. Dynavax is advancing CpG 1018 adjuvant as a premier vaccine adjuvant with adjuvanted vaccine clinical programs for shingles and Tdap, and through global collaborations, currently focused on adjuvanted vaccines for COVID-19, plague, seasonal influenza and universal influenza. For more information about our marketed products and development pipeline, visit </font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">www.dynavax.com</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Forward-Looking Statements</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">This press release contains &#34;forward-looking&#34; statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to a number of risks and uncertainties. All statements that are not historical facts are forward-looking statements. Forward-looking statements can generally be identified by the use of words such as &#x201c;anticipate,&#x201d; &#x201c;believe,&#x201d; &#x201c;continue,&#x201d; &#x201c;could,&#x201d; &#x201c;estimate,&#x201d; &#x201c;expect,&#x201d; &#x201c;forecast,&#x201d; &#x201c;intend,&#x201d; &#x201c;will,&#x201d; &#x201c;may,&#x201d; &#x201c;plan,&#x201d; &#x201c;project,&#x201d; &#x201c;potential,&#x201d; &#x201c;seek,&#x201d; &#x201c;should,&#x201d; &#x201c;think,&#x201d; &#x201c;toward,&#x201d; &#x201c;will,&#x201d; &#x201c;would&#x201d; and similar expressions, or the negatives thereof, or they may use future dates. Forward-looking statements made in this document include statements regarding our expected financial results and market share as of and for the year ended December 31, 2024, expectations regarding future growth and market share, the timing of IND filings, initiation and completion of clinical studies, expected timing for data readouts, and interaction with regulators. Actual results may differ materially from those set forth in this press release due to the risks and uncertainties inherent in our business, including, the risk that actual demand for our products may differ from our expectations, risks relating to our ability to commercialize and supply HEPLISAV-B, risks related to the timing of completion and results of current clinical studies, risks related to the development and pre-clinical and clinical testing of vaccines containing CpG 1018 adjuvant, as well as other risks detailed in the &#34;Risk Factors&#34; section of our Quarterly Report on Form 10-Q for the three months ended March 31, 2024 and periodic filings made thereafter, as well as discussions of potential risks, uncertainties and other important factors in our other filings with the U.S. Securities and Exchange Commission. These forward-looking statements are made as of the date hereof, are qualified in their entirety by this cautionary statement and we undertake no obligation to revise or update information herein to reflect events or circumstances in the future, even if new information becomes</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;"></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img191369596_0.jpg" alt="img191369596_0.jpg" style="width:134px;height:19px;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">available. Information on Dynavax's website at </font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">www.dynavax.com</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> is not incorporated by reference in our current periodic reports with the SEC.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">For Investors/Media:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Paul Cox</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">pcox@dynavax.com</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">510-665-0499</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Nicole Arndt</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">narndt@dynavax.com</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">510-665-7264</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;"></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img191369596_0.jpg" alt="img191369596_0.jpg" style="width:134px;height:19px;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">DYNAVAX TECHNOLOGIES CORPORATION</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(In thousands, except per share amounts)</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(Unaudited)</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:95.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:47.181%;"></td>
    <td style="width:9.476%;"></td>
    <td style="width:2.139%;"></td>
    <td style="width:15.934%;"></td>
    <td style="width:2.139%;"></td>
    <td style="width:5.058%;"></td>
    <td style="width:2.139%;"></td>
    <td style="width:15.934%;"></td>
   </tr>
   <tr style="height:14.4pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td colspan="6" style="padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid #000000;padding-right:0.075in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">Three Months Ended</font></p></td>
   </tr>
   <tr style="height:14.4pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td colspan="6" style="padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid #000000;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">March 31,</font></p></td>
   </tr>
   <tr style="height:15.85pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td colspan="2" style="padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid #000000;padding-right:0.075in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">2024</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid #ffffff03;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td colspan="2" style="padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid #000000;padding-right:0.075in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">2023</font></p></td>
   </tr>
   <tr style="height:15.1pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Revenues:</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:15.1pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Product revenues, net</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">$</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">47,845</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">$</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">43,451</font></p></td>
   </tr>
   <tr style="height:15.85pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="range_a7"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Other revenue</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid #000000;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid #000000;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">2,945</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid #ffffff03;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid #000000;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid #000000;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">3,474</font></p></td>
   </tr>
   <tr style="height:15.1pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">Total revenues</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">50,790</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">46,925</font></p></td>
   </tr>
   <tr style="height:15.1pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:15.1pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Operating expenses:</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:15.1pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Cost of sales &#x2013; product</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">10,966</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">14,712</font></p></td>
   </tr>
   <tr style="height:15.1pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Research and development</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">13,528</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">13,605</font></p></td>
   </tr>
   <tr style="height:15.1pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Selling, general and administrative</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">44,065</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">36,543</font></p></td>
   </tr>
   <tr style="height:15.85pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Bad debt expense</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">-</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">12,313</font></p></td>
   </tr>
   <tr style="height:15.85pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">Total operating expenses</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="border-top:1pt solid #000000;padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid #000000;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="border-top:1pt solid #000000;padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid #000000;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">68,559</font></p></td>
    <td style="border-top:1pt solid #ffffff03;padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid #ffffff03;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="border-top:1pt solid #000000;padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid #000000;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="border-top:1pt solid #000000;padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid #000000;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">77,173</font></p></td>
   </tr>
   <tr style="height:15.1pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:15.1pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Loss from operations</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;&#160;(17,769)</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;&#160;(30,248)</font></p></td>
   </tr>
   <tr style="height:15.1pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:15.1pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Other income (expense):</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:15.1pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Interest income</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;9,468</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;6,597</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:15.1pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Interest expense</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;&#160;&#160;&#160;(1,695)</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;&#160;&#160;&#160;(1,686)</font></p></td>
   </tr>
   <tr style="height:15.1pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Sublease (expense) income</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;&#160;&#160;&#160;(1,602)</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,598</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:15.85pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Other</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;101</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid #ffffff03;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;23</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:15.1pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Net loss before income taxes</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;&#160;(11,497)</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;&#160;(23,716)</font></p></td>
   </tr>
   <tr style="height:15.85pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Benefit from (provision for) income taxes</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,776</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid #ffffff03;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(616)</font></p></td>
   </tr>
   <tr style="height:15.85pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">Net loss</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:2.25pt double;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">$</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:2.25pt double;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;&#160;&#160;&#160;(8,721)</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:2.25pt double #ffffff03;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:2.25pt double;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">$</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:2.25pt double;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;&#160;(24,332)</font></p></td>
   </tr>
   <tr style="height:15.85pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">Net loss per share attributable to common</font></p></td>
    <td rowspan="2" style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td rowspan="2" style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td rowspan="2" style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td rowspan="2" style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td rowspan="2" style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td rowspan="2" style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td rowspan="2" style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:15.1pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">stockholders:</font></p></td>
   </tr>
   <tr style="height:15.85pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Basic</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:2.25pt double;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">$</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:2.25pt double;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;(0.07)</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:2.25pt double #ffffff03;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:2.25pt double;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">$</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:2.25pt double;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;(0.19)</font></p></td>
   </tr>
   <tr style="height:16.55pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Diluted</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:2.25pt double;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">$</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:2.25pt double;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;(0.07)</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:2.25pt double #ffffff03;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:2.25pt double;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">$</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:2.25pt double;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;(0.19)</font></p></td>
   </tr>
   <tr style="height:42.5pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">Weighted-average shares used in computing net loss per share attributable to common stockholders:</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:15.85pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Basic</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:2.25pt double #000000;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:2.25pt double #000000;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">130,200</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:2.25pt double #ffffff03;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:2.25pt double #000000;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:2.25pt double #000000;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">127,921</font></p></td>
   </tr>
   <tr style="height:16.55pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Diluted</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:2.25pt double #000000;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:2.25pt double #000000;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">130,200</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:2.25pt double #ffffff03;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:2.25pt double #000000;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:2.25pt double #000000;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">127,921</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;"></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img191369596_0.jpg" alt="img191369596_0.jpg" style="width:134px;height:19px;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">DYNAVAX TECHNOLOGIES CORPORATION</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">SELECTED BALANCE SHEET DATA</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(In thousands)</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(Unaudited)</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:86.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.3%;"></td>
    <td style="width:3.18%;"></td>
    <td style="width:2.74%;"></td>
    <td style="width:17.78%;"></td>
    <td style="width:7.48%;"></td>
    <td style="width:2.74%;"></td>
    <td style="width:17.78%;"></td>
   </tr>
   <tr style="height:15.1pt;white-space:pre-wrap;word-break:break-word;">
    <td rowspan="2" style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" rowspan="2" style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">March 31,</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" rowspan="2" style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">December 31,</font></p></td>
   </tr>
   <tr style="height:15.1pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td colspan="2" style="padding-left:0.075in;display:none;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-left:0.075in;display:none;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:15.85pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td colspan="2" style="padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid #000000;padding-right:0.075in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">2024</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid #ffffff03;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td colspan="2" style="padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid #000000;padding-right:0.075in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">2023</font></p></td>
   </tr>
   <tr style="height:15.1pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">Assets</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:15.1pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Cash, cash equivalents and marketable securities</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">$</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">723,538</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">$</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">742,302</font></p></td>
   </tr>
   <tr style="height:15.1pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Inventories</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">61,806</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">53,290</font></p></td>
   </tr>
   <tr style="height:15.85pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Other current assets</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid #000000;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid #000000;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">65,942</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid #ffffff03;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid #000000;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid #000000;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">63,528</font></p></td>
   </tr>
   <tr style="height:15.1pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">Total current assets</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">851,286</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">859,120</font></p></td>
   </tr>
   <tr style="height:15.85pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Total non-current assets</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid #000000;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid #000000;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">135,279</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid #ffffff03;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid #000000;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid #000000;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">137,976</font></p></td>
   </tr>
   <tr style="height:15.85pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">Total assets</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:2.25pt double #000000;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">$</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:2.25pt double #000000;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">986,565</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:2.25pt double #ffffff03;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:2.25pt double #000000;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">$</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:2.25pt double #000000;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">997,096</font></p></td>
   </tr>
   <tr style="height:15.85pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:15.1pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">Liabilities and stockholders&#x2019; equity</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:15.1pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Total current liabilities</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">$</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">56,002</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">$</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">62,195</font></p></td>
   </tr>
   <tr style="height:15.1pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Total long-term liabilities</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">312,083</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">312,829</font></p></td>
   </tr>
   <tr style="height:15.85pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Stockholders&#x2019; equity</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid #000000;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid #000000;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">618,480</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid #ffffff03;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid #000000;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:1pt solid #000000;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">622,072</font></p></td>
   </tr>
   <tr style="height:15.85pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">Total liabilities and stockholders&#x2019; equity</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:2.25pt double #000000;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">$</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:2.25pt double #000000;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">986,565</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:2.25pt double #ffffff03;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:2.25pt double #000000;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">$</font></p></td>
    <td style="padding-left:0.075in;vertical-align:middle;border-bottom:2.25pt double #000000;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">997,096</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;"></div>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img191369596_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img191369596_0.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" %Y"E$# 2(  A$! Q$!_\0
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MI1L7TKP?K6)_G?WF7/+N_O-'_A,_%W_0RWW_ (&/_C1_PF?B[_H9;[_P,?\
MQK.V+Z4;%]*/K6)_G?WASR[O[S1_X3/Q;_T,E]_X&/\ XT#QEXK'+>([XC_K
M\?\ QK.V+Z4;%]*/K6(_G?WBYY=W]Y]+_L+_ !^N;77Y/ACXNU:61;YFDTV:
MXD+$R#K'SZCFOK@2HPX-?EOIE_=Z/J-OJVFSM#<6LRRP2J>4=3D$?0BOT&_9
MY^+NF_&/X?67B!=BWD($6H0J>4F4<_@1R/:OZ'\*>*GCL,\LQ,O?A\-^J_K^
MM3Z#*<5[2G[&6ZV\UV^7Y/R/0MXSG%&\4 (1D4NQ?2OV:.VA['NB;Q1O%+L7
MTHV+Z57O![HF\4;Q2[%]*-B^E'O![HF\4;Q2[%]*-B^E'O![HF\4;Q2[%]*-
MB^E'O![HF\4;Q2[%]*-B^E'O![HF\4;Q2[%]*-B^E'O![HF\4;Q2[%]*-B^E
M'O![HF\4;Q2[%]*-B^E'O![HF\4;Q2[%]*-B^E'O![HF\4;Q2[%]*-J^E'O!
M[HGFKG%>#?MO?'9OA_X17P7X<O=NJZO&59HVPT,'\3?4\@?0U[!X\\5Z1X&\
M-WGBG6;A8K>SMVDD8GJ/3ZGH/K7YU_%7X@ZG\4O'5]XQU5VW7,O[F-CQ%&/N
MH/H/US7Y?XF\5?V)E7U6C+][4T]%_7]:GF9EBE0H\D?BE^"ZO]%\WT,U?&GB
MS^'Q'?@=O]+<?U_R:7_A,_%W_0RWW_@8_P#C6=L7THV+Z5_,'UK$?SO[SYOG
MEW?WFC_PF?B[_H9;[_P,?_&C_A,_%W_0RWW_ (&/_C6=L7THV+Z4?6L3_._O
M#GEW?WFC_P )GXN_Z&6^_P# Q_\ &C_A,_%W_0RWW_@8_P#C6=L7THV+Z4?6
ML3_._O#GEW?WFB?&/BWOXDOO_ Q_\:!XS\7%LCQ'?;NF?M3D_3K6=M6O3?V6
M/@K-\6_B)#]KMC_9=@PEOI#T8@_*GXFO2RK#YCFV/IX6C)N4FEO^)=-5*U10
MBW=^9]$?L5_#'Q#H/A'_ (3KQ9?W4EUJBYMX[B9F\N+Z'H37O$3@(!_3%-L;
M*VL;..SMH52.- JHO10!TJ3RU]*_L3(\JIY/EM/"TW?E6K\^I]?1I0HTE!=/
MQ\P\P4;Q2A%' %&Q?2O9]XU]T3>*-XI=B^E&Q?2CW@]T^=_^"@^J7^F^ =)E
MTZ^FA9M0(9XG92WR].*^2/\ A,_%O;Q)??\ @8_^-?6?_!19%7X?:.!_T$F_
M] KX[V+Z5_*WBGB*T.+*D5)KW8[/R/F,TDXXQV;V7Y&C_P )GXN_Z&6^_P#
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M  ;3?XUA #IMI<+_ '17VGL*/\B^Y?Y'Y_\ 6L8MJLE_V]+_ #-S_A:'Q/\
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M_MZ7^9N?\+0^)_\ T4W7/_!M-_C1_P +0^)__13=<_\ !M-_C6'A?[HHPO\
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M_P )GXM_Z&6^_P# Q_\ &L[8OI1L7TH^M8G^=_>'/+N_O-$^,_%N/^1EOO\
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M^)K867-!^JZ/U_JY^HVE:QIVKZ?'J&G7T<T,PW1212!E8>Q!JVLBD<&O@'X
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M*78OI1L7TH#00N,<5N?#CX@Z[\,O%5MXIT"Y99()%W1C[LBYY4_6L38OI2%
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MNY(V=*<#7]&(_E/E5D^V@44450!1110 4U@3TZ=*=0(IIOE@B+,SA5QW)[4
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M\C\\?,]J/,]J=@>E&!Z5_#Y\8-\SVH\SVIV!Z48'I0 WS/:CS/:G8'I1@>E
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M[W_;Q_+?BIG?]K<3.A3=X8=<B[<][U'ZWM!_X HHHK[P_-0HHHH ***,XZT
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MR]0\SVH\SVIV!Z48'I7YR>>-\SVH\SVIV!Z48'I0,;YGM1YGM3L#TI/EZ8H
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MWBJR@MMV^R_K8]<^#?PRTGX4^!+3PKIMLNZ.,&XD_P">DAY)/XUV$;G'*?\
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MC>:=11J.XW>:-YIU%&H7&[S1O-.HHU"XW>:-YIU%&H7&[S1O-.HHU"Y\Y?\
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MQ@W>:-YIU% #=YHWFG44 -WFO1_V278_'C0^/^7@_P C7G5>C_LE?\EYT/\
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MW?M%/\<?VJ-0T+3K\S:3X3SI]DJOE#)G,KC_ (%Q_P !-?+H]VS7]+\#Y/\
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M=V%_>:7>PZC83M%/!(LD,BG!5@<@UH>-O&_B/XA>(YO%'BB]\^ZF50S>@
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M7&Y>FS!FC8,*DI&&Y<8J7&ZLQ7/E3]M;]F^:<3?%7P=I_P \?.JV\*]1C_6
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M&Y>C+TZB@+C<O1EZ=10%QN7HR].HH"XW+T9>G44!<;EZ,O3J* N-R]&7IU%
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MC<O1EZ=168AN7HR].HH ;EZGTHM_:=OG_GLO\ZBJ?3/^0E;_ /79?YUOA?\
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MVFCXW^#VJ?L^^)-0+WWA243:4)'^9[*5B<#_ ')-P^C**_)IAGY<U[!^P?\
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M?&#</1AZ=10 W#T8>G44 -P]>C_LDA_^%\:'_P!?!_D:\ZKT?]DK_DO.A_\
M7PW\J]SAG_D?8?\ Q(VPW^\T_P#%'\T?H*@DV#Z4[#TJ?<'TI:_MB'PGV=QN
M'HP].HK2P<PW#T8>G446#F&X>C#TZBBP<PW#T8>G446#F&X>C#TZBBP<PW#T
M8>G5"9Y$5F<?=Y_"D"NQTQ"1,TK87;\V:_%3_@LM^TL/C/\ M,O\/=%OO,TG
MP7&;1O+?*/>$_O6^HX3ZJU?J;^VS^T98?LU?LV>)/BC>RQBXM]/:+38F/^MN
MW&V)/^^R"?8&OY_=8UC4/$&KW6O:Q<O-=WUT\]Q-(<L[NQ+,?<DU^M^%N2^T
MQ53,ZBTA[D?\3^)_*.G_ &]Y'XKXQ9][#!T<GIRLZGOS_P $7[B_[>FF_P#M
MSS*N?FP:=2!<<TM?MQ_/:?D%%%% !10<XX%'..: WN(_3%>P_L*_L]WG[27[
M2?A[P%% TEC'=+=:J0IPEO&=S9^O2O'SFOUC_P""&?[,H\)?"W4OCQX@L&CU
M#Q$^S3C(O*VJ'''^\W\J^9XNSC^Q<CJUT_??NQ_Q2Z_)7?R/KN!<B_UAXDHX
M>4;TU[\_\,;:?]O2M'Y^1][>'])M-!TVUT?38EC@M[=8XHU&-J@8 _*M'#U#
M:)(C99L[OO58K^77KN?V!\(W#T8>G446#F&X>C#TZBBP<PW#T8>G446#F&X>
MC#TZBBP<PW#T8>G446#F&ABIPU0S.-WFQG[O!%3,F3G-,AMO*+?-G=0/W>I\
M+?\ !;G]F4?$WX"0_&KP_IWF:MX1D,EQMCY>R?B0?\!.UO8;C7X_Y8#'<U_2
M=\0_">D^-_"FH>$->LUGL=1LY+:YA9<AT=2K#\B:_GN_:=^"6J_L[_'CQ)\)
MM523;I>H,+.:1<>?;O\ -%)^*%2<<9R*_<O"_./K&!J9=4?O4WS1_P +>J^4
MO_2C^>/&/(GA\QI9K25HUER3?:<5[K?^*"M_VYYG!KTI:1=P)##'/2EK]6/Q
M=;!1110 4444 2:?>W>FZA#J-E*4FAF#QN&QM8<CGZU^]?\ P3X_:1L?VD?V
M8?#WC&2\635(;<6FL*6^99XP%)/U&&_&OP.*#=G/4<U]U?\ !#[]I?\ X5U\
M:;WX&Z_?!=.\31B2Q\QOE2Z3H!_O+D>YQ7P/B'D_]J9&ZT%>='WEYQ^TONU^
M1^E>%F>O)^(5AYNU/$>X_*?V']]X_P#;WD?L A9UW &G8>HX92T6,@MUJ0.V
MS+=:_G4_J7W@P]&'I5)(YI:+"N-P]&'IU%%@YAN'HP].HHL',-P]&'IU%%@Y
MAN'HP].HHL',-P]&'IU%%@YAN'J.Z4FW?>,C;R*FIEQDPMCTHL',?B9_P60_
M9Z_X4[^U))XUT>P\O2O&5N+]6C7"BZ'$P_'*O_P*OD=<@XS7[5?\%AOV<Q\:
M/V4M0\0:79>9JOA.7^T[5HTRQ15_>H._*$GZ@5^*N6#;67':OZ6X$S;^U>'J
M?,[SI^X_E;E?_@-OFF?R=XE9*LFXJJ."M3K?O8]KR;4U\IINW1-#J***^R/@
M@HHHH */K10>: (RAW;J_2K_ ((/_M(?9KG7/V>-?U#Y9/\ B8:0LC=!TD4?
MC@_C7YL!3G)->@?LO?&?4?@!\=_#GQ1L)F5;#4D^VA2?G@8[7'_?//U%>#Q+
ME/\ ;>2U<+;WFKQ_Q+5??M\SZ3@_//\ 5OB&CC;V@I6GYPEI)_)/F]8H_HC@
M8(WE@_3WJPPSTKGO OB72O&'AG3O%&AW:S6MY9I+!(&R&1AD'-;L)>1]QZ#B
MOY6E'DDXL_LJ_-'F3),/1AZ=2.2!D4K!<3#TV0LB[C^M.$A"[GJCX@U:TTO2
M)]3O9UCAAC9I)'; 4 9)/X416H>\?GS_ ,%WOVE5T#X<:/\ L^Z#>@76O3?:
M]62-ONVT;?(#_O-G_OFORG5@WS GGUKV#]O#X^7O[1W[37B3Q]).6L5O&M-,
M3=D);Q':O'OC)]S7C\:A0<#J<U_4G".3K)<AI8=JTVN:7^*6K7RT7R/XYXVS
M^7$7%%?$P=Z:]R'^&.B:\F[R_P"WAU%%%?2'RX4444 %%%(Q(QC\: ;L+7T5
M_P $N/V?C\??VL]%M]0L/.TK0'&IZEN7Y2L9!53]6VBOG-6&[!)XYQW/T_6O
MV!_X(;_LW_\ "OOV?;KXPZ[8^7J'BRZWV^Y/F%JGRI^!;<WTVU\IQIF_]C\/
MU9Q=IS7)'UEN_DKOY'VGA_D?]O<44825Z=-^TGZ0:LO^WI.,?1L^X;'_ (\D
MACBVJ.-OI5D*RC -,CMRN<2&IE&!BOYB/ZZYAN'HP].HHL',-P]&'IU%%@YA
MN'HP].HHL',-P]&'IU%%@YAN'HP].HHL',-P]&'IU%%@YAN'HP].H[9J9:!<
MX']H'XD1_"_X9ZGXJ:8+<)#Y5I&3UE?A1^N?H#7YVW<US>W4EY=2M)))(7=V
MY+,3DFOH;_@H#\53KOBVU^&NG7/^CZ8/-O=IX:9ONC_@*Y_.OGFOY8\4L^_M
M3/GAJ;]REI\^I\OFF(]MB.1;1T^?7]%\AN'HP].HK\P/-&X>C#TZB@8W#T8>
MG4,<#- KC"&[U]E_L$?"F3PSX(F\=ZC;[;G5I,1%EY$0Z?F:^5/A9X+O?B-X
M[TWPC:I\UW=*K$#[J=23^%?H[X2T2T\,Z+::)9P^7';6ZQ1KC'"C%?LWA'D$
ML5F$\QJ+2&B]>Y[&3T>:HZKZ:+U?^2_,TP).]+AZ=17](1B?1<PW#T8>G455
M@YAN'HP].HHL',-P]&'IU%%@YAN'HP].HHL',-P]&'IU%%@YAN'JO?0?:H#;
M2@,DBE64]^*M4A56Y(K.5/GO&6S#F/SH_:.^&<_PM^*NI: L16V>0S638X,3
M$D#\.GX5PGS'HU?9?[?WPG'B/P+;_$#3+?-QH[XN-HY,+D#/_ 3@_0FOC92#
MR!7\>\=Y%+(>(:M)+W)/FCZ,^1QU'ZOB7%+1ZKT?^6PF'HP].HKXTY!N'HP]
M.HH ;AZ0*X.:?10(]@_8M^*+^ OBC'H=[=;;/6%%N^YN%?\ A/YU]U6^6CRI
MZ\]:_+>RO)].U"+4+:3;)#(K(1V-?HI^S]\28/B7\,-+\0I*K2>2([K'59%'
M.?\ />OZ&\(<^]MA9Y;4>L=8^G5'OY/B+QE1?35>G7\=?F=QAZ,/2HV]=P%+
M7[B>US#</1AZ=13L/F&X>C#TZBBP<PW#T8>G446#F&X>C#TZBBP<PW#T8>G4
M46#F&X>C#TZBBP<PW#T8>G446#F&X>C#TZBBP<PW#T8>G446#F&X>FRETB9L
M]%S3V.%)]J\T_:7^.%I\'/A]<7\;HVI7:F'3X.^\C[Y'HO>N#,<PP^68*>)K
M.T8JYG4J1IP<YZ);GBO[<OQ^>XE_X5'X9N_E7YM6DC;OVB_QKYB*R$Y)JSJN
MH7VM:G-J^IW+37%Q,TDTCG)9C4-?QQQ-G^(XBS:>*J/3:*[(^1Q&(GB:SG+Y
M+LNB_KK<;AZ,/3J*^=,!N'HP].HH ;AZ,/3J* &X>C#TZB@!N'HP].HH ;AZ
M,/3J* &X>B-Y89%D0D,OS*0>A%.H[YJHRE&2:$?;7[&OQ\?XD>$O^$4UV[5M
M5TQ0K;F^:6/H&]SZU[C$TKYS^'/6OS2^&7Q!UGX8>,[/Q?HUPPDMY,R1C_EJ
MF>5/UK]#_AKX^T?XB>#K/Q;H<ZR0W4(;&>8SW4^X/%?U%X:\61SK+5A<1+][
M35O5=SZ?+<8\12Y)?%'\5T?Z/_@G0X>C#T*^>M.Y[U^I*47L>G<;AZ,/3J*J
MP<PW#T8>G446#F&X>C#TZBBP<PW#T8>G446#F&X>C#TZBBP<PW#T4ZBBP<Q^
M6>L!O[3GS_SW;^=0X>K&L_\ (4F_Z[M_.H:_@NI\;/AY?$QN'HP].HK,0W#T
M8>G44 -P]3Z4&_M.WS_SV7^=15/IG_(2M_\ KLO\ZWPO^]0]5^8C],?!(?\
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MTZBBP<PW#T8>G446#F/G+_@HL''P]T?/_02;_P!!KXZP]?8__!1C_DGNC_\
M81;_ -!KXZK^4O%?_DKZG^&/Y'R^:O\ VQ^B_(;AZ,/3J*_-3SAN'HP].HH
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MY*\G/_\ D2XC_!+\C&N_W$_1_D?GCAZ,/3J*_A\^,&X>C#TZB@!N'HP].HH
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M_P!=E_G6^%_WJ'JOS$?ICX)1CX2TPY_Y<8O_ $ 5K;#67X(_Y%#3/^O&+_T
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M_([ZM_V$)O\ T8:_#/&G_=\-ZL\/.G[M/Y_H9&PT;#3J*_GL\*XW8:-AIU%
M7&[#1L-.HH"XU5(D6OT<_9\C;_A3WA_G_F&1?RK\Y1_K%K]'?V?/^2.^'_\
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MZL[K_"M%][N_N/YE\7,[>8<00P,)>YAUKYU)6<ONCRKUY@HHHK](/RD****
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M#3J*_$SQ1NPT;#3J*!W&[#1L-.HH"XW8:-AIU% 7&[#1L-.HH"XW8:-AIU%
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MJ*+!S,;L-&PTZBBP<S*NJ(1I\W_7-OY5^9OCQ2?&VK#_ *B,W_HPU^FFJ_\
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M;#3MP]:-P]: N-V&C8:=N'K1N'K0%QJJ1(M?HY^SY&?^%/>'SG_F&1?RK\Y
M1YB\U^CO[/C#_A3OA_G_ )AD7\J_:O!G_D98C_"OU/8R5OVT_3]4=EL-&PT[
M</6C</6OZ,BE8^ANQNPT;#3MP]:-P]:?*@NQNPT;#3MP]:-P]:.5!=C=AHV&
MG;AZT;AZT<J"[&[#1L-.W#UHW#UHY4%V-V&C8:=N'K1N'K1RH+L;L-&PT[</
M6C</6CE078W8:-AIVX>M&X>M'*@NQNPT;#3MP]:-P]:.5!=C=AHV&G;AZT;A
MZT<J"[&[#1L-.W#UHW#UHY4%V?.7_!19"OP]T<9_YB3'_P =KXZV&OL;_@HP
M1_PKW1^?^8BW_H-?'>X>M?REXK_\E?4_PQ_(^7S5_P"V/T7Y#=AHV&G;AZT;
MAZU^:GG7&[#1L-.W#UHW#UH"XW8:-AIVX>M&X>M 7/HW_@G.I/C'7/\ KRC_
M /0C7V#L-?'_ /P3F/\ Q6.N?]>4?_H1K["W#UK^LO"__DD:?^)_DCZC*F_J
M,?G_ .E,;L-&PT[</6C</6OT7E1Z-V-V&C8:=N'K1N'K1RH+L;L-&PT[</6C
M</6CE078W8:-AIVX>M&X>M'*@NQNPT;#3MP]:-P]:.5!=C=AHV&G;AZT;AZT
M<J"[&[#37AWC#'CT]:DW#UHW#UI<O8+LK7%K$Z>4X7#\;:^-OVR_V;Y/!FKR
M?$GPE9L=-O),WL*J<02'^+Z&OM!U1_O5G>*/#NC^)=&GT75[-9[>ZC,<D;=U
M(KY7BKAG#\297*A5^):Q?5/U\SEQ>'CBJ/(]'T?9_P!;GY?;6W;?SIVPUZ)^
MT;\#]3^"WC.2S57DTN[8OIMTPX9?[A]Q7G:MD9R.E?R%F66XK*<;/"XB-I1=
MO^"?)5(SIU'"2LT&PT;#3MP]:-P]:X";C=AHV&G;AZT;AZT!<;L-&PT[</6C
M</6@0U=\3B4#HP^937T5X1_:-_X3G]G'Q#\._%E^O]K66DN+2:1N;F(#_P!"
M%?.I"MU-*#@85R,C!VMV]*][(^(,9D=2?LG[LXN+71W6YM1Q%3#R;CU337>_
M^70:JDCK2[#3LCUHW#UKPC$;L-&PT[</6C</6D.XW8:-AIVX>M&X>M 7&[#7
MH_[)*'_A?&AC/_+P?Y&O.MP]:]&_9)(_X7SH?/\ R\'^5>YPS_R/L/\ XD;8
M;_>:?^*/YH_09(R$'-.V&A&&P<]J=N'K7]L07NGV=V-V&C8:=N'K1N'K5\J"
M[&[#1L-.W#UHW#UHY4%V-V&C8:=N'K1N'K1RH+L;L-&PTI8 9S3$E$@.#THY
M4'O T9*\FOF__@I;^THG[.?[,&N:O97OEZMJ<+6.DJ<9\R08S^ R?:OHY[L*
M&R.%')K\:?\ @M7^TN?BO^T&GPHT;4A)IOA&,QS*N"'NGY;IW48%?6\%Y+_;
M6>TZ<E>$/?EZ+I\W9'QO'V?2X=X:K5XNU2:Y(?XI+?\ [=C>7JD?&$\\]W<2
M75S*SR2,7D=CRS$Y)/OFDI%I:_IP_D.UM$PHHHH **** !NE-/3C\:<3@9/Z
M5Z?^QM\ [_\ :4_:(\.?"ZWMV:VN;U9]4D0'Y+6,[I,^F0-OU85SXJO2PN'E
M7JNT8IMOR2NS?!X?$8W%PPU!7G4<8Q7=MV7XO7RNS]2_^"+'[-1^#?[-Z_$+
M7;';JWC5A?2,T>&CM0,0)[?*=^/]OVK[.6W"'*_SK+\)Z'9>&M'M= TVU6&W
MM85CCB7@*H&  .W:MC</6OY/S;,*N;9E5Q=3>;;]%T7R5D?VKD^64<ERNC@:
M/PTXI7[O=R]9.[?FQNPT;#3MP]:-P]:\[E1Z5V-V&C8:=N'K1N'K1RH+L;L-
M&PT[</6C</6CE078W8:-AIVX>M&X>M'*@NQNPT;#3MP]:-P]:.5!=C=AHV&G
M;AZT;AZT<J"[&[#1L-.W#UHW#UHY4%V-V&C8:=N'K1N'K1RH+L;L-&PT[</6
MC</6CE079"Z!G 8_=YK/\0Z?;:S93:/?QK)!<0LC1LN0P(Q@^U:C1QL<DTV2
MV@DV[OX>G-./NL?,?S__ +?_ .SO<_LV?M.>(? _V9H]/NK@WNDLJ\&&4Y '
MT)(]J\6S_"37ZW_\%R_V9(_&_P (K3XZ^&M.W:AX9?&I2+U>U<X_1L?G7Y&I
MD[FS]*_J#A#./[<R*G6D_?C[LO\ $NOS5G\S^/N.\ACP[Q-4P\(VIS?/#_!*
M^G_;LKQ7DD2#VHI%&!2U]0?(H**** "BBB@#ZR_X(\_M+?\ "COVG[?P7KE]
MY6C^,E6Q?<PVI=9S"_/J<I_P-:_;"RV2(I0Y5OF4U_-'INIWVBZG;ZOIETT-
MQ:RI-;S1M\T;JP(;CI@C^7H*_?O]A;]HVS_:8_9H\._$FTG5KR2R6WU*,$?N
M[N/Y95]?O L/]D@U^)^*&2N&(IYG36DO<G_B7POYJZ_[=/Z"\',_53!ULGJR
M]ZG^\A?^23M-+RC-I_\ ;_D>T[#1L-"-\HRU.W#UK\BY4?MEV-V&C8:=N'K1
MN'K1RH+L;L-&PT[</6C</6CE078W8:-AIVX>M&X>M'*@NQNPT;#3MP]:-P]:
M.5!=C=AHV&G;AZT;AZT<J"[&[#05QR33MP]::P5QM8T60797D!>8AEW*HR*_
M-7_@O7^SN;G2] _:)T/3LO:R?8-6>->?+/,;G\<C-?ID8XRNW/ZUYQ^U=\$M
M(^/OP$\2?##4(%=M2TUTMV8_ZN4?-&WX,!^&:]WAO-O[%SJCBWLG:7^%Z/\
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M+(_M*WY_Y;+_ #K?"_[U#U7YBN?IEX)CSX1TPY_Y<8O_ $ 5K>7[UE^""/\
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M<*_] T0^I87_ )]K[CP+_AWK\'/^@IK7_@0G_P ;H_X=Z_!S_H*:U_X$)_\
M&Z]]^7VH^7VH_P!1N%?^@:(?4L+_ ,^U]QX%_P .]?@Y_P!!36O_  (3_P"-
MT?\ #O7X.?\ 04UK_P "$_\ C=>^_+[4?+[4?ZC<*_\ 0-$/J6%_Y]K[CP+_
M (=Z_!S_ *"FM?\ @0G_ ,;H_P"'>OP<_P"@IK7_ ($)_P#&Z]]^7VH^7VH_
MU&X5_P"@:(?4L+_S[7W'@7_#O7X.?]!36O\ P(3_ .-T?\.]?@Y_T%-:_P#
MA/\ XW7OOR^U'R^U'^HW"O\ T#1#ZEA?^?:^X\"_X=Z_!S_H*:U_X$)_\;H_
MX=Z_!S_H*:U_X$)_\;KWWY?:CY?:C_4;A7_H&B'U+"_\^U]QX%_P[U^#G_04
MUK_P(3_XW1_P[U^#G_04UK_P(3_XW7OOR^U'R^U'^HW"O_0-$/J6%_Y]K[CP
M+_AWK\'/^@IK7_@0G_QNC_AWK\'/^@IK7_@0G_QNO??E]J/E]J/]1N%?^@:(
M?4L+_P ^U]Q\<?M-?L>>'/A7X&'B_P #W-].+>8"\2ZD5L(?XAA1WKYT"98D
M-^'I7Z=^-_#.G>,/#%]X<U")7CN[9HV4KTR.OX5^;WC[PE>^!/&6H^%-00K)
M9W31_-W /!_*OP_Q0X5PV28JGB<)#EIR5FELFCQ<TPL:,XS@K)Z:=U_FOR9C
M>7[T>7[T[</6C</6OR,\R[&^7[T>7[T[</6C</6@+L;Y?O1Y?O3MP]:-P]:
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MQ_;F>5<0G[E^6/\ A6B^_?YG]C\&9&N'.':.#DOWEN:?^.6K^[2*\DA&!9L
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MOWH\OWIVX>M&X>M 78WR_>CYD;(;N*=N'K2?+G/X546XRNA'VG^Q=\>QX_\
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M%1C%621]/&/)%1BK)=!/+]Z/+]Z7<OK1N7UKKT+]X3R_>CR_>EW+ZT;E]:-
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M^3<HW[R@NA\V44V,;4QG\Z=7[,?@M^;4**** "BBB@!K9SS7[%?\$4_VE?\
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MO7C6UQYECI3&SL]K?*VT_.P^K=_05Y>I &":_D/Q"S[^W.(9N+]RG[J^6_\
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M3;E]:_J.,HU-3ZCWA-@HI=R^M%7H'O'Y:ZRN-4G'_3=OYU!L%6-9(_M2<_\
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MM&Y?6C0/>$V"H[J)"F6_*I=R^M(63O2?+87O'Q_^W-\ _P"Q]2_X6QX:LO\
M1[E]NJ1Q+Q')VD^A[U\WJG<U^GGB[P]I'BS0+CP]J]NLEO>1-'*C+P01BOSS
M^-WPJU+X0>/+KPS>1M]GW;[*9AQ)%G@_ATK^:?%#A+^SL9_:6&C^[G\2[/\
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M%.HJ@NQNP4;!3J* NQNP4;!3J* NQNP4;!3J* NQNP4;!3J* NQNP4;!3J*
MNQNP4;!3J* NQNP4;!3J* NQNP4;!3J* NQNP4;!3J* NQNP4;!3J* NQNP4
M;!3J* NQNP4;!3J* NQNP4;!3J* NQNP4;!3J* NQNP4;!3J* NRMJB#^SYO
M^N;?RK\SO'D+GQMJWR-_R$)NW_30U^FM[_QZO_NFO$M3_P"0G-_OG^=?D_BA
ME$,THT%*?+9OI<XL9@GC5%<UK7Z7WMYH^(?(?^XWY4>0_P#<;\J^V**_&_\
M4VC_ ,_G]R_S./\ L.7_ #]_\E_X)\3^0_\ <;\J/(?^XWY5]L44?ZFT?^?S
M^Y?YA_8<O^?O_DO_ -L?$_D/_<;\J/(?^XWY5]L44?ZFT?\ G\_N7^8?V'+_
M )^_^2__ &Q\3B!Q(OR-^5?HY^S[$!\'O#^?^@9%_*O.Q]Y?K7LG@W_D7;7_
M *Y+_*OU#PQR.&5XZM*,W*Z72W7U.K!Y?+ SE+GO=6VMU]6:6P4;!3J*_:TM
M#ONQNP4;!3J*878W8*-@IU% 78W8*-@IU% 78W8*-@IU% 78W8*-@IU% 78W
M8*-@IU% 78W8*-@IU% 78W8*-@IU% 78W8*-@IU% 78W8*-@IU% 79\Y_P#!
M1:(_\*]T<*I_Y"3'_P =KX[\A_[C?E7Z._&/_D&6_P#UT/\ *O.!]Y?I7\]^
M(7#M/,>))UG4:TBK6\O4\[%97+%5O:<]OE?]4?%/D/\ W&_*CR'_ +C?E7VQ
M17P_^IM'_G\_N7^9S_V'+_G[_P"2_P#VQ\3^0_\ <;\J/(?^XWY5]L44?ZFT
M?^?S^Y?YA_8<O^?O_DO_ -L?$_D/_<;\J/(?^XWY5]L44?ZFT?\ G\_N7^8?
MV'+_ )^_^2__ &QYK_P3HC8>,=<+*1_H4?\ Z$:^P-@KSCX/?\A.;_KG_6O2
M:_H?@/ QR_AV%%2O9[_<>CA<.\+AU3O>U];6W;?GW&[!1L%.HK[4Z+L;L%&P
M4ZB@+L;L%&P4ZB@+L;L%&P4ZB@+L;L%&P4ZB@+L;L%&P4ZB@+L;L%&P4ZB@+
ML;L%&P4ZB@+L;L%&P4ZB@+L;L%&P4ZB@+L;L%&P4ZB@+L;L%'EBG44K!<\7_
M &N?V=;7XM>&#KVA6JKKFGQYMG7K,HR3&?Z5\-W6GW=G=26=W;O')#(4D1EY
M4C@@_C7ZC7/3_@)KQOQ)_P A^\_Z^&_G7XEXD<(8#%8JGBH/DE+>RW//Q65Q
MQD_:1EROKI>_9[H^&?(?^XWY4>0_]QORK[8HK\Q_U-H_\_G]R_S.;^PY?\_?
M_)?_ +8^)_(?^XWY4>0_]QORK[8HH_U-H_\ /Y_<O\P_L.7_ #]_\E_^V/B?
MR'_N-^5'D/\ W&_*OMBBC_4VC_S^?W+_ ##^PY?\_?\ R7_[8^)_(?\ N-^5
M>C_LE0L/CQH>4;_CX/;V-?2-;/@'_D:+?ZUZV1\)TL/G%"HJK=I+I_P2J>32
MIU(S]I>S3V[/U/74C&P?2C8*5/N#Z4M?U'!:'L7&[!1L%.HJQ78TH ,U#,RO
M%L[L<"K!Z5 W]:"XGYB?\%W_ -I&9CH_[-FA7;#;B_UG9G_MDA_4_C7YJX;H
M%-?N+^T;_P E%N?HO\JX(=:_8N&^+*&2Y/2PM/#7MJWSVNWJW;D?IN]$C\;X
MH\.,5Q)G=;'U,:H\UHJ/LF^6,=$K^T5^K;LKMO0_'<JPZK2[7_NG\J_89OZ4
MM>Y_Q$/_ *A?_)__ +0^?_X@S4M_OZ_\%?\ W4_'C8_]T_E1L?\ NG\J_8>B
MG_Q$1?\ 0+_Y/_\ :"_X@W4_Z#U_X*_^ZGX\;'_NG\J KYX4U^P]"]1_NT?\
M1#7_ $"_^3__ &@_^(-5/^@]?^"?_NI^2'PY\!>(?B7XZT;X>>%[-KC4-:U*
M&RLX]NX%I'"@MZ*">?:OZ$/V=OA%H7P#^#_AWX5>'XU6WT?38K;*_P#+1@/G
MD/NS$L?=J\$^#?\ R4O2/^OK_P!EKZX/\-?GW&_%%;/I4J/L^2$;RM>]V]+[
M+9+3U9^A<"\#T>$56JNK[6=2T;\O+:,=;)<TMVTWKKRQTT! H;RSWYJ38*:.
MM25\"?H$ANP4;!3J*!78W8*-@IU% 78W8*-@IU% 78W8*-@IU% 78W8*-@IU
M% 78W8*-@IU% 78W8*-@IU% 78W8*-@IU% 78W8*-@IU% 78W8*-@IU% 78W
M8*-@IU% 78W8*-@IU% 78W8*-@IU% 78W8*-@IU% 7979#)(?:ORI_X+M?LR
M2>'O&VE?M':#I[?9]1 L=8\L<"0<QN?J,CZXK]6N]>9_M1_\D[E_Z[1?^A5[
M_#.<5LCSFGB::O\ 9:O:Z>EKZ^36FZ/"XJX?H<3Y'5P%27+>THRM?EE'5.UU
M?JFKJZ;5S^>,(V.$_*EV/_=/Y5^PR?=I:_7_ /B(:_Z!?_)__M#\;_X@U4_Z
M#U_X)_\ NI^/&Q_[I_*C8_\ =/Y5^P]%/_B(B_Z!?_)__M!?\0;J?]!Z_P#!
M7_W4_'C8_P#=/Y4;'_NG\J_8>BC_ (B(O^@7_P G_P#M _X@W4_Z#U_X*_\
MNI^.[+)G C8_A74?!+XH:_\ !3XJ:#\4O#Q;[1HNHI.H5=N]0?G3Z,I(K]8%
M^\?I2_P_\"K.IQ]3K4Y4YX2Z:::Y]T]&O@[%T?![%8>M&I2S&THM--4=4TTT
MU^][I,^M/@[\0]%^*WPYT7Q]HL_G6NJ:?%=6[?[+KD?S-=9'*). *XOX&_\
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MJZO^[_\ ;'Q/Y#_W&_*CR'_N-^5?;%%<_P#J;1_Y_/[E_F']AR_Y^_\ DO\
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MPY?\_?\ R7_[8^)_(?\ N-^5'D/_ '&_*OMBBC_4VC_S^?W+_,/[#E_S]_\
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#S__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>dvax-20240508.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2024-05-08T13:42:52.6503+00:00 -->
<!-- Copyright (c) 2024 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://www.dynavax.com/20240508" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:dvax="http://www.dynavax.com/20240508" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" namespace="http://fasb.org/us-gaap/2023"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.dynavax.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:roleRef roleURI="http://www.dynavax.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="dvax-20240508.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://www.dynavax.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10010.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10130.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10020.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10000.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10090.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10100.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10120.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10110.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10040.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10050.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10060.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10070.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10030.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10080.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10140.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10190.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10180.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10210.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10340.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10170.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10220.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10160.0" priority="2" use="optional"/>
        </link:presentationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139904028989552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>May 08, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  08,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Dynavax Technologies Corporation<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001029142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-34207<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">33-0728374<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2100 Powell Street, Suite 720<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Emeryville<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94608<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">510<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">848-5100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DVAX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>7
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M\%:<)K4\N$H33U"5@P!/V!/%+B-P#X/]M3LJPFD-#K6?%XOZ]6O0:R2K:D"
M)^S_D(VUSH&L$1"7;00\.OSC^7K&#51UN2!^\-/\9S)E40[Q5GO8:%"R\0FU
M;6ID]'I!/GA74/))1A59TR1'8:O4'^"Y>J9H;(-NNDWGLC;D&@1&7P=_8"15
MF@_PE'SP$WEXBU94+-G)PVZ#T/-@.AI\J6-RCZZ<]OK^1.VI4).$+4#)NVI#
M;E:[&_&N8V16W$+GTL"=MFBN&(4PLP/@_4)*<^C8BVWY?XG^OU!+ P04
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M2>C@W(-@[^&5C!W-CQ]W]P-02P,$%     @ JH"H6"0>FZ*M    ^ $  !H
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M_0QI-^2!8ECFS_A[QA?_&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%
M  @ JH"H6 =!36*!    L0   !               ( !     &1O8U!R;W!S
M+V%P<"YX;6Q02P$"% ,4    " "J@*A8W-,$.^\    K @  $0
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M<R\N<F5L<U!+ 0(4 Q0    ( *J J%@ZJJ+G0 $  #P"   /
M  "  640  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "J@*A8)!Z;HJT
M  #X 0  &@              @ '2$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL
M+G)E;'-02P$"% ,4    " "J@*A899!YDAD!  #/ P  $P
M@ &W$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"   !%
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="dvax-20240508.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="dvax-20240508.htm">dvax-20240508.htm</File>
    <File>dvax-20240508.xsd</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "dvax-20240508.htm": {
   "nsprefix": "dvax",
   "nsuri": "http://www.dynavax.com/20240508",
   "dts": {
    "inline": {
     "local": [
      "dvax-20240508.htm"
     ]
    },
    "schema": {
     "local": [
      "dvax-20240508.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://www.dynavax.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_2db3973c-8965-47ee-910d-aaea40667e8d",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dvax-20240508.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_2db3973c-8965-47ee-910d-aaea40667e8d",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dvax-20240508.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.dynavax.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.dynavax.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.dynavax.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.dynavax.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.dynavax.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.dynavax.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.dynavax.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.dynavax.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.dynavax.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.dynavax.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.dynavax.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.dynavax.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.dynavax.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.dynavax.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.dynavax.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.dynavax.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.dynavax.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.dynavax.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.dynavax.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.dynavax.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.dynavax.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.dynavax.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0000950170-24-055612-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-24-055612-xbrl.zip
M4$L#!!0    ( *J J%@J\0O^[!(  !2;   1    9'9A>"TR,#(T,#4P."YH
M=&WM/6E7X[B6W_M7Z-'SNJDS*/&^A.4=FJ+J9;H*&$+-ZS-?^LC6-=$KQT[;
M#B3SZ^=*MK- PIH4 <('(-%ZK^ZN*VGO'\->3*X@RT6:[/^J-[1?"21ARD5R
MN?_K8>>HW?[U'P<_[?V-4O+Q4_N$G, U.0P+<04?11[&:3[(@&QWOGX@[206
M"9 _?CO_0CZFX: '24$HZ19%O]5L7E]?-W@DDCR-!P6.E3?"M-<DE%:='V7
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M#$8[$ Q_B0"GKW2$N_&'_GBLXUB97-CQ./'T?PQV?PH1B3%Q=N?@\.33ZVE
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MY1TS%H%OBP RZCPCIX''2/7Q:-;\N;GI 2-ZDCF324>)*.XQQ]N4UT^"8 X
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M ;M?@6+[[)'N AI\0+M?O MUC$CSE)L/^;X#.J9#-=U^,. UU\)@VI!^VLR
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M   1              "  0    !D=F%X+3(P,C0P-3 X+FAT;5!+ 0(4 Q0
M   ( *J J%@G1,FY80@  $E=   1              "  1L3  !D=F%X+3(P
M,C0P-3 X+GAS9%!+ 0(4 Q0    ( *J J%BB; JIR2@  #_  @ /
M      "  :L;  !D=F%X+65X.3E?,2YH=&U02P4&      ,  P"[    H40
#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>dvax-20240508_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="dvax-20240508.xsd" xlink:type="simple"/>
    <context id="C_2db3973c-8965-47ee-910d-aaea40667e8d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
        </entity>
        <period>
            <startDate>2024-05-08</startDate>
            <endDate>2024-05-08</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d"
      id="F_75becf8f-f109-4bae-842c-7e6b3c939eca">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d"
      id="F_4e225ced-fb02-4b4f-9e9a-b32a00633a57">0001029142</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d"
      id="F_ad6185ca-5257-49be-a98e-a95167b9594b">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d"
      id="F_6b55f726-1acb-40e9-9b2c-7ec5742e7863">2024-05-08</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d"
      id="F_70eb8451-bd9d-4903-9893-5e89ee02ba6a">Dynavax Technologies Corporation</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d"
      id="F_c2c1c5ee-ca76-4bb8-8725-d1e07103cd80">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d"
      id="F_d830263e-189a-4788-a098-058756b10993">001-34207</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d"
      id="F_3219ff50-3915-43e5-a6b6-0f4755a121fe">33-0728374</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d"
      id="F_94b7fb45-27a9-4741-be24-1619db7ec962">2100 Powell Street, Suite 720</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d"
      id="F_69a38850-caeb-433f-8098-a35460ea1010">Emeryville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d"
      id="F_66f5dee4-4cb8-4d5f-8e78-59c20ec660e9">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d"
      id="F_9c7afb6d-53b3-4d2e-b89e-ab8535e9b9e8">94608</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d"
      id="F_356321f3-54ef-41b3-ab22-993d50760ae4">510</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d"
      id="F_b2c7cda4-0c75-4250-9046-58ad8b7696ea">848-5100</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d"
      id="F_c0e8c46e-b78c-4493-b2d1-8dc6f0f5a35b">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d"
      id="F_7148ba86-7055-4882-8614-d125d96b4ff3">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d"
      id="F_f70fc3d6-3ec2-4608-8dcb-9f73ce6c3596">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d"
      id="F_0ba37612-ae59-435a-9d36-37e8919874c6">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d"
      id="F_f66454e4-3551-4ff2-866d-5f840b1ff944">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d"
      id="F_757c5e5c-14b4-49ea-b5e2-24aff97a6351">DVAX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d"
      id="F_1a2dd896-4895-4e85-a860-e4238f16b684">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_2db3973c-8965-47ee-910d-aaea40667e8d"
      id="F_9e883700-6d4a-4dd9-b514-74deb4b4b8b3">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
